Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)
Diseases of the Cardiovascular System
What is the purpose of this trial?
PACeS is a trial to study most effective treatment for patients who may experience atrial fibrillation after cardiac surgery, particularly coronary artery bypass grafting (CABG). Atrial fibrillation, or Afib (AF), is an irregular heart rhythm. In some cases, AF can cause blood clots. There are currently 2 classes of drugs for preventing blood clots in patients with AF. Antiplatelets, like aspirin, and anticoagulants, or blood thinners. This study aims to determine whether the addition of blood thinners to antiplatelets will improve treatment outcomes in patients who develop AF after CABG.
- Ages18 years and older
- Trial withIcahn School of Medicine at Mount Sinai (ISMMS)
- Start Date03/01/2021
- End Date12/31/2022
- Last Updated11/15/2022
- Study HIC#2000027269